Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride
Authors:
- David M BaileyDBDavid M Bailey
Abstract
No abstract availableKeywords
Funding Information
- Merck
This publication has 24 references indexed in Scilit:
- Is transurethral resection of the prostate still justified?BJU International, 1999
- Factors influencing morbidity in patients undergoing transurethral resection of the prostateUrology, 1999
- DOUBLE-BLIND RANDOMIZED STUDY OF SYMPTOMS ASSOCIATED WITH ABSORPTION OF GLYCINE 1.5% OR MANNITOL 3% DURING TRANSURETHRAL RESECTION OF THE PROSTATEJournal of Urology, 1998
- THE TREATMENT OF GROSS HEMATURIA SECONDARY TO PROSTATIC BLEEDING WITH FINASTERIDEJournal of Urology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-upUrology, 1998
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Symptoms of the Transurethral Resection Syndrome Using Glycine as the IrrigantJournal of Urology, 1995
- Endocrine therapies for symptomatic benign prostatic hyperplasiaUrology, 1994
- Treatment of Prostatic Bleeding: Suppression of Angiogenesis by Androgen DeprivationJournal of Urology, 1993